A recent study has identified the interleukin enhancer-binding factor 3 (ILF3), which is overexpressed in primary colorectal cancer (CRC) patient samples and correlated with poor prognosis, to support the mRNA stability of serine/glycine biosynthesis genes. The gene discussed is ILF3; the disease is colorectal cancer.